Home » Newsletters » BioWorld Science

BioWorld Science

March 14, 2006

View Archived Issues

CKD-501 well tolerated in healthy subjects

Dopamine receptor occupancy of YKP-1358 determined

Potential antitumor activity of SIRT1 inhibitors / News in Context

Neurocrine Biosciences updates progress across pipeline

Neuromed supports calcium channel blocker programs with Series D financing

AC Immune identifies lead compounds for Alzheimer's disease

Epix completes enrollment in phase IIb study of EP-2104R

Allergan receives FTC approval for Inamed acquisition

VX-702 produces dose-dependent increase in ACR20 response rates

ALGRX-4975 meets primary endpoint of decreased pain for tendonitis patients

Active RA patients achieve ACR20 following HuMax-CD20 treatment

Snapshots of new dental research

Dimethylcurcumin claimed as a potential topical agent for acne vulgaris

Ad-IU-1 shows good profile as gene therapy for prostate cancer

Acadia presents new nonpeptidergic UII receptor agonists

XMRV: A novel virus behind prostate cancer?

Anticancer efficacy of satraplatin in vitro, in vivo and in patients with advanced solid tumors

Nikken Chemical obtains manufacturing and marketing rights for Selenica tablet

CV Therapeutics begins shipments of Ranexa

IND clearance for pharmacokinetic study of Nebido

New phase II study for SP-01A in treatment experienced HIV-infected patients

NICE recommends PDT to treat common skin cancer and premalignant lesions

LA-419 effective in a human model of thrombosis

GPR119 agonist identified and found to reduce food intake in a rat model of obesity

Kowa acquires the remaining common shares of Nikken Chemicals, bringing its ownership to 100%

StemCells receives IRB approval for phase I Batten disease study of HuCNS-SC

Kamada cleared to begin phase III trials of alpha1-proteinase inhibitor

Braintree inlicenses rights to chemoprevention agent BLI-600

Amgen updates AMG-714 progress

New antiglaucoma agents disclosed in recent patents

Anti-HCV drugs prepared and tested at Bristol-Myers Squibb

New patents describe therapeutic agents for asthma, COPD, emphysema, etc.

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 24, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...